A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting
Public ClinicalTrials.gov record NCT05059600. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Assessment of Safe-use Conditions for Administration of ZULRESSO in a Home Setting
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study was to evaluate whether the safe-use conditions for administration of brexanolone (ZULRESSO®) can be implemented in a home setting.
Study identification
- NCT ID
- NCT05059600
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 52 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 7, 2021
- Primary completion
- Jul 13, 2022
- Completion
- Jul 13, 2022
- Last update posted
- Sep 14, 2025
2021 – 2022
United States locations
- U.S. sites
- 6
- U.S. states
- 4
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sage Investigational Site | Culver City | California | 90230 | — |
| Virtual Site (recruiting nationwide) | Culver City | California | 90230 | — |
| Sage Investigational Site | Miramar | Florida | 33029 | — |
| Sage Investigational Site | Pompano Beach | Florida | 33060 | — |
| Sage Investigational Site | New York | New York | 10036 | — |
| Sage Investigational Site | League City | Texas | 77573 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Postpartum Depression trials
Other public records listing Postpartum Depression. Sorted by last update posted; newest first. Not a recommendation.
- NCT05700760: The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention Recruiting
- NCT06277661: The Mom and Infant Outcomes (MOMI) Study Recruiting
- NCT06004232: Prenatal Yoga to Prevent Postpartum Depression Active, not recruiting
- NCT05873569: Preventing Postpartum Depression in Immigrant Latinas Recruiting
- NCT05764213: Improving Maternal Mental Health & SUD Screening and Treatment Active, not recruiting
- NCT06818734: Implementation of a Clinical Decision Support Tool for Postpartum Depression Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05059600, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 14, 2025 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05059600 live on ClinicalTrials.gov.